Bianca Weinstock-Guttman, MD, is Professor of Neurology at the State University of New York at Buffalo, and Director of the Baird Multiple Sclerosis Center at The Jacobs Neurological Institute. She is also the Director of the Pediatric Multiple Sclerosis Center of the Jacobs Neurological Institute, one of six centers of excellence established by the National Multiple Sclerosis Society. In addition, she also serves as Executive Director of the New York State Multiple Sclerosis Consortium (NYSMSC).
Dr. Weinstock-Guttman received her medical degree from University of Bucharest, Romania. She completed an internship at Carmel Hospital, Haifa, Israel, and a neurology residency at Meir General Hospital, Tel Aviv University, Israel. Subsequently, she completed a neuroimmunology fellowship at the Mellen Center for MS Treatment and Research, Cleveland Clinic Foundation, Cleveland, Ohio. She is a member of several professional societies including the American Academy of Neurology, American Academy for the Advances of Sciences and she serves as a member of the Executive Committee of AAN MS subdivision. Additionally, she serves as a medical advisory member for the US National Multiple Sclerosis Society.
Dr. Weinstock-Guttman has been involved in multiple pivotal therapeutic clinical trials in MS and currently is involved in multiple phase III studies as well as in investigator-initiated phase I and IV studies. She has published more than 200 peer-reviewed articles in main Neurology and Immunology journals. She has also given several hundred poster presentations and is frequently invited as a guest lecturer at multiple national and international conferences. Her current special research interests are in better understanding the heterogeneity of MS, identifying predictors of disease progression with a primary focus on genetic and environmental interactions and influences on MS disease phenotype, and response to therapy and influences on physical and neurocognitive status. Pediatric MS, a new and insufficiently explored subject, is an important area of her clinical and research interest as part of a well-established national network. Dietary supplementation and modification as well as the vascular theory of MS and influence on the pathobiology of MS also represent a more recent focus of Dr. Weinstock-Guttman’s research. Her research is funded from various agencies including but not limited to the National Institutes of Health, Department of Defense, National Multiple Sclerosis Society, NSF as well as the pharmaceutical industry.